Kevin Joseph Fitzgerald Alnylam Pharmaceuticals, Inc. (ALNY) insider trading activity
Kevin Joseph Fitzgerald is CSO & EVP, Head of Research of ALNYLAM PHARMACEUTICALS, INC.. Currently has a direct ownership of 21,264 shares of ALNY, which is worth approximately $6.89 Million. The most recent transaction as insider was on Jul 01, 2025, when has been sold 7,763 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
21.3K
57.5%
3M change
49.95%
12M change
Total Value Held
$6.89 Million
Kevin Joseph Fitzgerald Transaction History
Also insider at
KJF
Kevin Joseph Fitzgerald
CSO & EVP, Head of Research
New York, NY